Eva Amatya

Biochemistry, Genetics and Molecular BiologyComputer ScienceChemical EngineeringEnergy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Recent advances toward the development of Hsp90 C-terminal inhibitors”.

Recent advances toward the development of Hsp90 C-terminal inhibitors

Bioorganic & Medicinal Chemistry Letters(2022)10.1016/j.bmcl.2022.129111

N/A

0DataRank · unranked

39 citations

Brian S. J. Blagg, Eva Amatya

Synthesis and evaluation of 3′- and 4′-substituted cyclohexyl noviomimetics that modulate mitochondrial respiration

Bioorganic & Medicinal Chemistry(2022)10.1016/j.bmc.2022.116940

N/A

0DataRank · unranked

5 citations

Eva Amatya, Sukhmanjit Kaur, Monimoy Banerjee, Ang Zuo, Rick T. Dobrowsky +2 more

The Investigation of Hsp90C‐Terminal Inhibitors Containing Amide Bioisosteres

ChemMedChem(2024)10.1002/cmdc.202400418

N/A

0DataRank · unranked

2 citations

Chitra Subramanian, Reagan Long, Kelli McNamara, Mark S. Cohen, Brian S. J. Blagg +1 more

Development of Hsp90 C-terminal inhibitors with noviomimetics that manifest anti-proliferative activities

RSC Medicinal Chemistry(2024)10.1039/d3md00529a

N/A

0DataRank · unranked

7 citations

Chitra Subramanian, Mark S. Cohen, Brian S. J. Blagg, Eva Amatya